Like the kid on the playground who watches others hop on and off the spinning merry-go-round, Boston Scientific says it will sit out the current whirl of medtech mergers. Following last week’s second-quarter earnings report, president and CEO Michael Mahoney told analysts that the Natick, MA–based company would continue to grow its business organically, with the possibility of a few “tuck-in” acquisitions to contribute to that growth.
Hey, check out all the research scientist jobs. Post your resume today!
